Sealonix, Inc.
PrivateLast Round
Series A
May 12, 2023
Total Funding Raised
$20M
Momentum Score
25 /100
Company Overview
Sealonix, Inc. is a medical device company focused on the development and commercialization of hemostatic sealants using its proprietary biomaterials.
Sector
Enterprise Software
Verticals
Data Integration, Workflow Automation, Sales Enablement, CRM, Marketing
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sealonix, Inc. Comps
Public and private peers based on sector, stage, and business model.
Sealonix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 12, 2023 |
Sealonix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TiE Boston | Series A |
| Sparta Group LLC | Series A |
| J2 Ventures | Series A |
| Excelestar Ventures | Series A |
| AMED Ventures | Series A |
| Iyengar Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2023
$20M round led by Excelestar Ventures.
Sealonix, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sealonix, Inc.'s valuation, stock price, and market status.